DNAprint Genomics (DNAG)

[Porgie Tirebiter]

This is a really great development, to see some people actually doing a little research, and move this discussion past the blur and fuzz of "very undervalued IMHO".

With today's share price, total market cap is still about one thirteenth of what we know this company owes to creditors. And those numbers are old, so one must assume they are currently even greater than that, as we have another year of deffered compensation, capitol leases, etc. etc. etc. There is an awful lot of debt in line in front of the shareholders.

I have a question, I really don't know the answer to it, but I am curious; Would too much of an increase in market cap actually encourage Dutchess to pull the plug at some point and force a bankruptcy? Or would this be a non-factor?

As for the comparison some one made with ACTC, It might be useful to point out that at least ACTC still seems to be an active company. Not that I would invest there, but at least they seem to be open for business and reporting to shareholders, the SEC, and bothering to pay the fee for an annual report.